Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Aherne

Showing results (121-130 of 139) with videos related to

Pageof 14
Sort By:
Cancer Chemotherapy and Pharmacology|January 1, 1996
Antitumour evaluation of dolastatins 10 and 15 and their measurement in plasma by radioimmunoassayG W Aherne, A Hardcastle, M Valenti, et al.
Hematological Oncology|January 1, 1987
Cytosine arabinoside in the management of recurrent leukaemiaT S Ganesan, M J Barnett, R J Amos, et al.
Investigational New Drugs|January 1, 1984
The pharmacokinetics of subcutaneous bolus cytosine arabinoside in an arachis oil plus aluminium distearate suspensionM L Slevin, E M Piall, A Johnston, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1985
Small intestinal transit time affects methotrexate absorption in children with acute lymphoblastic leukemiaA D Pearson, A W Craft, E J Eastham, et al.
Molecular Pharmacology|March 14, 1998
Modulation of fluorouracil cytotoxicity by interferon-alpha and -gammaA Ismail, C J Van Groeningen, A Hardcastle, et al.
Cancer Investigation|October 13, 1999
Vinblastine pharmacokinetics in patients with non-small cell lung cancer given cisplatinM Links, S Watson, K Lethlean, et al.
British Journal of Cancer|February 14, 1998
Comparison of plasma and tissue levels of ZD1694 (Tomudex), a highly polyglutamatable quinazoline thymidylate synthase inhibitor, in preclinical modelsG W Aherne, E Ward, N Lawrence, et al.
British Journal of Anaesthesia|November 1, 1988
Relative bioavailability of controlled release morphine tablets (MST continus) in cancer patientsP Poulain, P J Hoskin, G W Hanks, et al.
Oncology Research|January 1, 1997
Determinants of cytotoxicity with prolonged exposure to fluorouracil in human colon cancer cellsQ Ren, C J Van Groeningen, A Hardcastle, et al.
British Journal of Cancer|October 14, 2005
A phase I pharmacokinetic and pharmacodynamic study of BGC9331 and carboplatin in relapsed gynaecological malignanciesT Benepal, A Jackman, L Pyle, et al.
Pageof 14

Showing results (121-130 of 139) with videos related to

Sort By:
Pageof 14
Cancer Chemotherapy and Pharmacology|January 1, 1996
Antitumour evaluation of dolastatins 10 and 15 and their measurement in plasma by radioimmunoassayG W Aherne, A Hardcastle, M Valenti, et al.
Hematological Oncology|January 1, 1987
Cytosine arabinoside in the management of recurrent leukaemiaT S Ganesan, M J Barnett, R J Amos, et al.
Investigational New Drugs|January 1, 1984
The pharmacokinetics of subcutaneous bolus cytosine arabinoside in an arachis oil plus aluminium distearate suspensionM L Slevin, E M Piall, A Johnston, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1985
Small intestinal transit time affects methotrexate absorption in children with acute lymphoblastic leukemiaA D Pearson, A W Craft, E J Eastham, et al.
Molecular Pharmacology|March 14, 1998
Modulation of fluorouracil cytotoxicity by interferon-alpha and -gammaA Ismail, C J Van Groeningen, A Hardcastle, et al.
Cancer Investigation|October 13, 1999
Vinblastine pharmacokinetics in patients with non-small cell lung cancer given cisplatinM Links, S Watson, K Lethlean, et al.
British Journal of Cancer|February 14, 1998
Comparison of plasma and tissue levels of ZD1694 (Tomudex), a highly polyglutamatable quinazoline thymidylate synthase inhibitor, in preclinical modelsG W Aherne, E Ward, N Lawrence, et al.
British Journal of Anaesthesia|November 1, 1988
Relative bioavailability of controlled release morphine tablets (MST continus) in cancer patientsP Poulain, P J Hoskin, G W Hanks, et al.
Oncology Research|January 1, 1997
Determinants of cytotoxicity with prolonged exposure to fluorouracil in human colon cancer cellsQ Ren, C J Van Groeningen, A Hardcastle, et al.
British Journal of Cancer|October 14, 2005
A phase I pharmacokinetic and pharmacodynamic study of BGC9331 and carboplatin in relapsed gynaecological malignanciesT Benepal, A Jackman, L Pyle, et al.
Pageof 14